Unravelling the memory of the extracellular matrix using MASH-derived decellularized scaffolds

This study demonstrates that the extracellular matrix retains a "memory" of metabolic dysfunction-associated steatohepatitis (MASH) that persists after decellularization, actively promoting steatosis, fibrosis, and metabolic dysfunction in both in vitro and in vivo settings, thereby confirming that diseased ECM can drive disease progression even when repopulated with healthy cells.

The Gist

The Big Idea: The "Ghost" in the Machine

Imagine you have a house. Over time, the house gets messy, the paint peels, and the walls get stained with grease because the people living there had a very unhealthy diet. Now, imagine you could magically remove all the people and their furniture, leaving only the empty shell of the house—the bricks, the pipes, and the wiring.

In science, this empty shell is called the Extracellular Matrix (ECM). It's the "scaffolding" that holds cells together.

Usually, scientists thought that if you cleaned out a diseased house (a sick liver) and put healthy new people (healthy cells) inside, the house would just be an empty container. They thought the new people would fix the house.

This paper proves that idea wrong.

The researchers discovered that the "empty house" (the scaffold) actually remembers how sick it was. Even after the sick cells are gone, the walls and pipes still carry a "memory" of the disease. If you put healthy cells into a sick scaffold, those healthy cells start acting sick, too. It's like the house itself is whispering to the new tenants, "Hey, we eat greasy food and don't exercise here," causing the new tenants to become unhealthy.

The Experiment: The "Sick Scaffold" Test

The scientists wanted to see if this "disease memory" was real, specifically for a condition called MASH (Metabolic dysfunction-Associated Steatohepatitis), which is basically a very fatty, inflamed, and scarred liver.

1. Making the Sick Liver: They took rats and fed them a terrible diet (high fat, high sugar) plus a chemical to make their livers very sick and fatty.
2. The "Ghost" Extraction: They removed all the living cells from these sick rat livers, leaving only the "ghost" scaffolds (the MASH-ECM).
3. The Swap: They took these sick scaffolds and transplanted them into two groups of rats:
   • Group A: Rats that already had sick livers.
   • Group B: Rats with perfectly healthy livers.

What Happened?

The results were shocking.

• In the Sick Rats: The sick scaffold fit right in and stayed sick. No surprise there.
• In the Healthy Rats: This is the big discovery. Even though the recipient rats were healthy, once the sick scaffold was put inside them, the healthy cells that grew into the scaffold became sick.
  • The healthy cells started storing fat (steatosis).
  • They started building scar tissue (fibrosis).
  • They started acting exactly like they belonged in a diseased liver.

The Analogy: Imagine planting a healthy apple seed in a pot of soil that was previously used to grow poisonous weeds. Even if you water the apple seed perfectly, the soil's "memory" of the weeds makes the apple tree grow twisted and sick. The soil (the scaffold) dictated the health of the plant (the cells).

The "Why": Lipids and Signals

Why did this happen? The researchers found a few reasons:

1. The Grease Trap: Even after washing the scaffold, a lot of fat (triglycerides) remained stuck in the walls of the scaffold. It was like a sponge soaked in oil that wouldn't dry out.
2. The Chemical Whisper: The scaffold released chemical signals that told the new cells, "Stop burning fat and start storing it."
3. The Broken Phone Line: When they tested the cells' ability to communicate (using calcium signals, like electrical impulses), the cells in the sick scaffold had a "broken phone line." They couldn't respond properly to signals, making them sluggish and dysfunctional.

The Human Connection

The team also tested this with human liver tissue from patients who had MASH and liver cancer. Even though this tissue was very diseased, they managed to grow human liver cells on it. The cells survived, but they showed the same "sick" behaviors.

This is a double-edged sword:

• The Bad News: You can't just take a discarded, fatty liver, clean it out, and use it for a transplant without fixing the "memory" first. If you do, you might accidentally give the patient a new liver that quickly becomes fatty and scarred again.
• The Good News: The scaffold is still strong enough to hold life. This means if we can figure out how to "wipe the memory" of the scaffold (clean the grease and fix the signals), we could turn these discarded, "marginal" livers into life-saving organs for people waiting for transplants.

The Bottom Line

This paper tells us that the environment matters more than we thought.

Think of the liver scaffold not just as a passive building, but as an active teacher. A healthy scaffold teaches cells how to be healthy. A diseased scaffold teaches cells how to be sick.

The Conclusion: Before we can use diseased livers to build new organs for transplants, we need to find a way to "reprogram" the scaffold, scrubbing away the disease memory so it can teach healthy cells how to be healthy again.

Technical Summary

1. Problem Statement

• Organ Shortage: There is a critical global shortage of donor livers for transplantation, exacerbated by the rising prevalence of Metabolic Dysfunction-Associated Steatohepatitis (MASH).
• Marginal Organs: Many discarded livers from MASH patients are currently unusable for direct transplantation but could potentially be repurposed as acellular liver scaffolds (ALS) for tissue engineering.
• The "ECM Memory" Hypothesis: While healthy decellularized scaffolds have been shown to support regeneration, it is unknown whether scaffolds derived from diseased livers retain a "memory" of the disease. The central question is whether a MASH-derived extracellular matrix (ECM) can actively induce steatohepatitis features in healthy cells or maintain the disease phenotype in a new host, thereby hindering regeneration.

2. Methodology

The study employed a multi-modal approach combining in vivo animal models, in vitro cell culture, and advanced omics technologies.

• Animal Model & Induction:
  • Induction: Female Wistar rats were induced with MASH using a "multiple-hit" protocol: a high-fat diet (45% kcal from palm oil, 20% fructose, 2% cholesterol) + sucrose water + intraperitoneal Carbon Tetrachloride (CCl₄) injections.
  • Groups: Donor rats (MASH and Healthy) and Recipient rats (MASH and Healthy).
• Decellularization:
  • Rat Livers: Perfusion-based decellularization using Triton X-100 and Sodium Dodecyl Sulfate (SDS). The SDS perfusion time was extended to overcome the resistance of steatotic tissue.
  • Human Livers: Specimens from MASH/HCC patients were decellularized using a physical/chemical agitation protocol (Tissue Lyser) with a specific reagent mix (Sodium Chloride, SLS, Triton X-100, Sodium Deoxycholate, Trypsin).
• Transplantation (In Vivo):
  • Partial hepatectomy (10%) was performed on recipient rats.
  • MASH-derived ECM fragments were orthotopically transplanted into either Healthy or MASH recipient rats.
  • Analysis was conducted 30 days post-transplantation.
• In Vitro & Ex Vivo Models:
  • Recellularization: HepG2 cells were seeded onto MASH and Healthy ECM scaffolds.
  • Conditioned Medium: HepG2 cells were cultured in medium conditioned by MASH ECM to test for soluble factors.
  • Calcium Signaling: Intracellular Ca²⁺ dynamics were monitored in recellularized scaffolds using Fluo-4 AM and ATP stimulation via confocal microscopy.
• Analytical Techniques:
  • Histology: H&E, Sirius Red (fibrosis), Oil Red O (lipids), Immunohistochemistry (Desmin, α-SMA).
  • Metabolomics: Untargeted LC-HRMS (Liquid Chromatography-High Resolution Mass Spectrometry) to profile metabolic changes.
  • Molecular Biology: RT-qPCR for lipogenic (Srebp1c, Acaca) and fibrotic (Col1a1) genes.
  • Imaging: Scanning Electron Microscopy (SEM) and Second Harmonic Generation (SHG) for collagen architecture.

3. Key Contributions

• First Demonstration of MASH ECM Memory: This is the first study to show that decellularized ECM from MASH livers retains a pathological "memory" capable of inducing steatohepatitis features in healthy environments.
• Translational Feasibility: It investigates the viability of using discarded marginal livers (MASH) for ALS generation, a crucial step for addressing organ shortages.
• Mechanistic Insight: The study elucidates that the disease phenotype is driven not just by residual lipids, but by structural ECM cues and retained bioactive molecules that reprogram cell metabolism and signaling.

4. Key Results

• Characterization of MASH ECM:

  • MASH-derived scaffolds were denser, opaque, and heavier than healthy scaffolds.
  • Lipid Retention: Unlike healthy decellularization, MASH decellularization failed to remove all lipids; triglyceride levels in MASH ECM remained comparable to the original liver tissue.
  • Structural Changes: SHG and SEM revealed disorganized, bundled collagen fibers in MASH ECM compared to the organized, thin fibers in healthy ECM.

• In Vivo Transplantation Outcomes:

  • Recellularization: MASH ECM was successfully recellularized in both healthy and MASH recipients.
  • Phenotype Induction: Crucially, healthy recipients transplanted with MASH ECM developed steatosis (lipid accumulation) and fibrosis within the graft.
  • Molecular Changes: The grafts showed upregulation of Srebp1c (lipogenesis) and Col1a1 (fibrosis).
  • Metabolomics: Recellularized MASH ECM in healthy hosts acquired a metabolic profile similar to MASH liver (enriched in lipids, glycerophospholipids), distinct from healthy controls. This suggests the ECM actively reprograms the host microenvironment.

• In Vitro & Ex Vivo Findings:

  • Lipid Accumulation: HepG2 cells cultured on MASH ECM or in MASH-conditioned medium accumulated significant lipid droplets (confirmed by BODIPY staining), mimicking the disease phenotype.
  • Calcium Signaling: HepG2 cells on MASH ECM showed reduced amplitude and altered dynamics in ATP-induced Ca²⁺ signaling compared to healthy ECM. There was an upregulation of the ITPR3 calcium channel isoform.
  • Human ECM: Human MASH/HCC-derived ECM also supported cell survival and allowed for diverse Ca²⁺ signaling patterns, proving that diseased human ECM can still function as a scaffold, though with altered physiology.

5. Significance and Conclusion

• Pathological Memory: The study confirms that the ECM is not a passive scaffold but an active regulator of cell physiology. MASH ECM encodes biochemical and structural signals that drive cells toward a steatohepatitic phenotype, even in a healthy host.
• Clinical Implication: Simply decellularizing a diseased liver is insufficient for creating a therapeutic graft. The "memory" of the disease (retained lipids, altered collagen, and bioactive mediators) must be actively erased or reprogrammed before the scaffold can be used for transplantation.
• Future Directions: The findings suggest that marginal livers could be a viable source for bioengineered organs if protocols are developed to "reprogram" the ECM memory (e.g., removing residual lipids, enzymatic remodeling of collagen) to restore a healthy microenvironment. This could significantly expand the donor pool for liver transplantation.